Search

Search Results

• TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2023038

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.038

  2391

  PDF: 1876

  HTML: 977

• PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES

  Stefano Lancellotti, Maria Basso, Raimondo De Cristofaro

  e2013058

  2013-09-01

  https://doi.org/10.4084/mjhid.2013.058

  3597

  PDF: 1232

  HTML: 24266

• EBV IN HODGKIN LYMPHOMA

  Giuseppina Massini, Doerte Siemer, Stefan Hohaus

  e2009013

  https://doi.org/10.4084/mjhid.2009.013

  1751

  PDF: 646

  HTML: 14156

• CUPROPTOSIS: A REVIEW ON MECHANISMS, ROLE IN SOLID AND HEMATOLOGICAL TUMORS, AND ASSOCIATION WITH VIRAL INFECTIONS

  MAURIZIO MARTINI, Pietro Tralongo, Mariagiovanna Ballato, Vincenzo Fiorentino, Walter Giordano, Valeria zuccalà, Cristina Pizzimenti, Arianna Bakacs, Antonio Ieni, Giovanni Tuccari, Guido Fadda, Luigi Maria Larocca

  e2025052

  2025-06-29

  https://doi.org/10.4084/MJHID.2025.052

  2003

  PDF: 1118

  HTML: 962

• EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?

  Pellegrino Musto, Dr. Nicola Sgherza

  e2024073

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.073

  1652

  PDF: 881

  HTML: 303

• Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

  Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

  e2025026

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.026

  2111

  PDF: 1757

  HTML: 447

• BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN

  Maria Teresa Voso, Giulia Falconi, Dr. Fabiani

  e2023055

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.055

  1989

  PDF: 1076

  HTML: 253

• NOVEL DRUGS IN FOLLICULAR LYMPHOMA

  Giuseppe Rossi, Antonella Anastasia

  e2016061

  2016-11-01

  https://doi.org/10.4084/mjhid.2016.061

  5888

  PDF: 1598

  HTML: 1668

  Untitled: 277

• THALASSEMIA AND VENOUS THROMBOEMBOLISM

  Julien Succar, Khaled M. Musallam, Ali T Taher

  e2011025

  2011-05-25

  https://doi.org/10.4084/mjhid.2011.025

  3092

  PDF: 1190

  HTML: 4701

• APLASTIC ANEMIA AND VIRAL HEPATITIS

  Laura Cudillo

  e2009026

  https://doi.org/10.4084/mjhid.2009.026

  1341

  PDF: 566

  HTML: 23228

• SARS-CoV-2 Transmission and Outcome in Neuro-rehabilitation patients hospitalized at Neuroscience Hospital in Italy SARS CoV 2 in severe neurological patients

  Francesco Di Gennaro

  e2020063

  2020-08-29

  https://doi.org/10.4084/mjhid.2020.063

  1203

  PDF: 769

  HTML: 272

• BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT IN SPLENIC MARGINAL ZONE LYMPHOMAS of ELDERLY PATIENTS.

  Roberto Castelli

  e2016030

  2016-07-01

  https://doi.org/10.4084/mjhid.2016.030

  5905

  PDF: 1035

  HTML: 2323

• TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo

  e2025039

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.039

  2644

  PDF: 1787

  HTML: 693

• UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)

  José Luis Piñana, Estela Giménez, Lourdes Vázquez, María Ángeles Marcos, Manuel Guerreiro, Rafael Duarte, Ariadna Pérez, Carlos de Miguel, Ildefonso Espigado, Marta González-Vicent, María Suarez-Lledó, Irene García-Cadenas, Rodrigo Martino, Angel Cedillo, Monserrat Rovira, Rafael de la Cámara, David Navarro, Carlos Solano

  e2024065

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.065

  4570

  Suppl. Files: 1241

  PDF: 1150

  Html: 307

• THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

  Elvira Pelosi, Dr. Germana Castelli, Ugo Testa

  e2022080

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.080

  1676

  PDF: 1258

  HTML: 611

• PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS

  Mario Sabatelli, Luca Laurenti, Marco Luigetti

  e2018057

  2018-09-01

  https://doi.org/10.4084/mjhid.2018.057

  1870

  PDF: 931

  HTML: 466

  Fig1: 282

  Fig.2: 298

  Fig. 3: 233

  Fig. 5: 242

  Fig. 4: 269

• BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL

  Ugo Testa, Elvira Pelosi, Germana Castelli, Patrizia Chiusolo

  e2024070

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.070

  1770

  PDF: 1155

  HTML: 174

• Parvovirus B19 infection in a patient with common variable immunodeficiency Parvovirus B19 infection in a patient with common variable immunodeficiency

  Magda Zanelli, Loredana Reggiani, Francesca Sanguedolce, Maurizio Zizzo, Giovanni Martino, Angelo Genua, Stefano Ascani

  e2021026

  2021-02-26

  https://doi.org/10.4084/mjhid.2021.026

  1168

  PDF: 446

  HTML: 329

• DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY MAJOR CONGENITAL THROMBOPHILIA

  alessandra serrao, benedetta lucani, davide mansour, antonietta ferretti, erminia baldacci, cristina santoro, robin foà, antonio chistolini

  e2019044

  2019-06-25

  https://doi.org/10.4084/mjhid.2019.044

  2047

  PDF: 1573

  HTML: 501

• IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?

  Giuseppe Gritti, Chiara Pavoni, Alessandro Rambaldi

  e2017010

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.010

  3569

  PDF: 1357

  HTML: 2395

  Fi.1 Gritti.Rambaldi: 255

• Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia

  Massimo Breccia, Gioia Colafigli, Luisa Quattrocchi, elisabetta abruzzese, giuliana alimena

  e2016016

  2016-02-20

  https://doi.org/10.4084/mjhid.2016.016

  2983

  PDF: 744

  HTML: 1968

  figure 1: 211

  figure 2: 214

• Possible treatment failure of artemether-lumefantrine in an Italian traveler with uncomplicated falciparum malaria.

  Ernestina Carla Repetto, Claudio Giacomazzi, Antonio Traverso

  e2011041

  2011-10-02

  https://doi.org/10.4084/mjhid.2011.041

  1853

  PDF: 703

  HTML: 3418

• ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

  Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica

  e2010026

  2010-08-31

  https://doi.org/10.4084/mjhid.2010.026

  1501

  PDF: 862

  HTML: 1037

• Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)

  Eugenio Galli, Silvia Bellesi, Marcello Viscovo, Federica Sorà, Stefan Hohaus, Nicola Piccirillo, Luca Laurenti, Patrizia Chiusolo, Valerio De Stefano, Simona Sica, Gina Zini

  e2021066

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.066

  1838

  PDF: 608

  HTML: 370

• THE TREATMENT OF ADVANCED-STAGE MYCOSIS FUNGOIDES AND SEZARY SYNDROME: A HEMATOLOGIST'S POINT OF VIEW.

  Antonio Giordano, Livio Pagano

  e2022029

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.029

  2541

  PDF: 1104

  HTML: 409

• Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging

  Pier Mannuccio Mannucci

  e2019056

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.056

  3036

  PDF: 1516

  HTML: 327

• Multiple Myeloma and Paget’s disease with abnormal skull lesions and intracranial hypertension

  Tommaso Caravita, Agostina Siniscalchi

  e2112068

  2012-11-04

  https://doi.org/10.4084/mjhid.2012.068

  1167

  PDF: 725

  HTML: 10864

• The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

  Michele Bibas

  e2024015

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.015

  2542

  PDF: 1807

  HTML: 1046

• ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS

  chiara mozzini, giancarlo pesce, alder casadei, domenico girelli, maurizio soresi

  e2019066

  2019-10-30

  https://doi.org/10.4084/mjhid.2019.066

  1529

  PDF: 952

  HTML: 1989

• INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY

  Giuseppe Leone, Livio Pagano

  e2018039

  2018-07-01

  https://doi.org/10.4084/mjhid.2018.039

  4444

  PDF: 1522

  HTML: 770

• CHANGES OF VON WILLEBRAND FACTOR DURING PREGNANCY IN WOMEN WITHOUT AND WITH VON WILLEBRAND DISEASE

  Giancarlo Castaman

  e2013052

  2013-07-16

  https://doi.org/10.4084/mjhid.2013.052

  3334

  PDF: 1117

  HTML: 8610

• Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax

  Claudio Fozza

  e2024011

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.011

  1798

  PDF: 1436

  HTML: 199

• Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.

  Francesco Autore, Patrizia Chiusolo, Federica Sora', Luca Laurenti, Livio Pagano, Andrea Bacigalupo, Valerio De Stefano, Simona Sica

  e2023009

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.009

  1235

  PDF: 1166

  HTML: 506

• ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THERAPY-RELATED MYELOID NEOPLASMS (t-MN) OF THE ADULT: MONOCENTRIC OBSERVATIONAL STUDY AND REVIEW OF THE LITERATURE.

  Elisabetta Metafuni, Patrizia Chiusolo, Luca Laurenti, Federica Sorà, Sabrina Giammarco, Andrea Bacigalupo, Giuseppe Leone, Simona Sica

  e2018005

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.005

  4317

  PDF: 1154

  HTML: 1453

• “IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

  Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin

  e2016047

  2016-10-15

  https://doi.org/10.4084/mjhid.2016.047

  4092

  PDF: 1119

  HTML: 3904

  Untitled: 199

  Cneo. Fig.1: 141

  Untitled: 132

  Untitled: 159

  Untitled: 168

• ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS

  saveria capria, silvia maria trisolini, clara minotti, caterina stefanizzi, luisa cardarelli, Martina Canichella, claudio cartoni, daniela diverio, maria stefania de propris, marco mancini, alessandra micozzi, robin foà, giovanna meloni

  e2012072

  2012-11-06

  https://doi.org/10.4084/mjhid.2012.072

  1757

  PDF: 870

  HTML: 969

  cover letter: 327

• 5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature

  Mariangela Greco, Marianna Criscuolo, Luana Fianchi, Livio Pagano, Maria Teresa Voso

  e2011011

  2011-03-14

  https://doi.org/10.4084/mjhid.2011.011

  1708

  PDF: 829

  HTML: 1128

• DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

  Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso

  e2022030

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.030

  1655

  HTML: 689

  PDF: 907

• BETA THALASSEMIA MAJOR IN A DEVELOPING COUNTRY: EPIDEMIOLOGICAL, CLINICAL AND EVOLUTIONARY ASPECT

  Mohamed Bejaoui, Naouel Guirat

  e2013002

  2013-01-01

  https://doi.org/10.4084/mjhid.2013.002

  1735

  PDF: 947

  HTML: 2543

• SICKLE CELL ANAEMIA AND MALARIA

  Lucio Luzzatto

  e2012065

  2012-10-03

  https://doi.org/10.4084/mjhid.2012.065

  11885

  PDF: 7330

  HTML: 24067

  Figures Malaria and SCK: 270

• Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists

  Monica Carpenedo, Dr, Dr, Dr

  e2023021

  2023-02-28

  https://doi.org/10.4084/MJHID.2023.021

  1312

  PDF: 1203

  HTML: 736

• EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies

  Mehran Karimi, Tahereh Zarei, Sezaneh Haghpanah , Azita Azarkeiva, Maryam Naderi , Sara Matin , Asghar Bazrafshan , Zohreh Zahedi , Afshan Shirkavand , Parisa pishdad, Vincenzo De Sanctis

  e2022026

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.026

  1819

  PDF: 787

  HTML: 247

• MONITORING OF PARTICLE ENVIRONMENTAL POLLUTION AND FUNGAL ISOLATIONS DURING HOSPITAL BUILDING-WORK ACTIVITIES IN A HEMATOLOGY WARD.

  Fabio Pattavina, Daniele Ignazio La Milia, Sara Vincenti, Barbara Fiori, Riccardo Torelli, Malgorzata Wachocka, Umberto Moscato, Simona Sica, Walter Ricciardi, Patrizia Laurenti

  e2019062

  2019-10-30

  https://doi.org/10.4084/mjhid.2019.062

  1524

  PDF: 852

  HTML: 286

• FAMILIAL MEDITERRANEAN FEVER: ASSESSING THE OVERALL CLINICAL IMPACT AND FORMULATING TREATMENT PLANS Familial Mediterranean Fever today

  Donato Rigante, Raffaele Manna, Prof.

  e2019027

  2019-04-25

  https://doi.org/10.4084/mjhid.2019.027

  7191

  PDF: 1913

  HTML: 843

• SCREENING OF HEPATITIS G AND EPSTEIN-BARR VIRUSES AMONG VOLUNTARY NON REMUNERATED BLOOD DONORS (VNRBD) IN BURKINA FASO, WEST AFRICA

  Issouf Tao, Cyrille Bisseye, Bolni Marius Nagalo, Mahamoudou Sanou, Alice Kiba, Guzin Surat, Tegwinde Rebecca Compaore, Lassina Traore, Albert Yonli, Jean-Baptiste Nikiema, Jean-Didier Zongo, Jacques Simpore

  e2013053

  2013-09-02

  https://doi.org/10.4084/mjhid.2013.053

  1606

  PDF: 812

  HTML: 2444

• THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA

  Francesca Ricci, Alessandra Tedeschi, Marco Montillo, Enrica Morra

  e2011031

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.031

  2417

  PDF: 1021

  HTML: 2463

• MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS

  Lucio Amitrano, Maria Anna Guardascione

  e2009014

  https://doi.org/10.4084/mjhid.2009.014

  861

  PDF: 579

  HTML: 4040

• PLASMA CELL LEUKEMIA UPDATE ON IMMUNOPHENOTYPE, MOLECULAR CHARACTERISTICS, AND THERAPY. The second part of plasma cell neoplasms with spreading in the blood and tissues Plasma Cell Leukemia

  Giuseppe G.M. Leone, Ugo Testa

  e2025080

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.080

  1740

  PDF: 427

  Html: 263

• COMPARISON OF THE CLINICAL AND LABORATORY FEATURES OF COVID AND INFLUENZA IN CHILDREN

  Davide Pata, Danilo Buonsenso, Piero Valentini

  e2022065

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.065

  1311

  PDF: 865

  HTML: 310

• Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient

  Gabriele Magliano, Annarosa Cuccaro, Francesco D'Alo', Elena Maiolo, Silvia Bellesi, Stefan Hohaus, Andrea Bacigalupo, Livio Pagano

  e2021054

  2021-08-28

  https://doi.org/10.4084/MJHID.2021.054

  1356

  PDF: 500

  HTML: 234